A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery

NCT06529432 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Local Analgesia Via Nerve Block

Interventions

DRUG: Bupivacaine Liposome Injection
DRUG: Bupivacaine Hydrochloride Injection

Sponsor

Jiangsu HengRui Medicine Co., Ltd.